Drug that calms ‘cytokine storm’ linked to 45% lower death risk in severe COVID-19: Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off a ventilator within a month, despite double the risk of additional infection. Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die […]
No comments:
Post a Comment